Malaria Diagnostics Market Size, Share, Growth Analysis, By Diagnostic Test(Rapid Diagnostic Tests, Molecular Diagnostic Tests and Microscopic Diagnostic Tests.), By End-User(Hospitals, Diagnostics Centers and Clinics), By Region - Industry Forecast 2025-2032

Based on the geography, the global malaria diagnostics market is segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Middle East & Africa is considered as the leading region in the global malaria diagnostics market. The African region had the highest revenue share of 88.17% in 2022. P. falciparum is the most prevalent malarial parasite in this region and was accounted for an estimated 99% of all cases in Africa. According to the WHO, an estimated 92.0% of global malaria cases and 93% of global malarial deaths were recorded in this region. These facts are indicative of the rising prevalence of malaria in Africa. This region bears the highest burden of malaria globally, with a substantial portion of malaria cases and deaths occurring here. Factors contributing to the dominance of this segment include the endemic nature of malaria in many countries across Africa, where the disease is a major public health concern. Additionally, limited access to healthcare resources, including diagnostic facilities and trained personnel, often demands for the use of RDTs and other point-of-care diagnostics in resource-constrained settings. Moreover, international organizations, governments and non-profit organizations have been actively involved in scaling up malaria control and elimination efforts in the region, thereby driving the demand for malaria diagnostics.

The fastest-growing region in the global malaria diagnostics market is likely the Asia Pacific. While Africa bears the highest burden of malaria globally, Asia Pacific is experiencing significant strides in malaria control and elimination efforts. In Southeast Asia, the market is estimated to hold the second position with India accounting for the largest share of the regional market. The Southeast Asian region is expected to grow at a CAGR of 5.0%. Countries such as India, Indonesia, and Myanmar, have made considerable progress in reducing malaria transmission through extensive vector control measures, improved access to healthcare services, and effective treatment strategies. As a result, there is a growing emphasis on accurate and timely diagnosis of malaria to support these elimination efforts. With the rising awareness about the disease and increasing funding from the private sector, the need for diagnostic testing and care-based surveillance systems is anticipated to increase. Huge investments in healthcare infrastructures and collaborations between governments, international organizations, and private sectors are driving the expansion of malaria diagnostic services in the Asia Pacific region.